US81730H1095 - Common Stock
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 204.8M 119.98% | 422.2M 106.15% | 621.154M 47.12% | 833.16M 34.13% | |||||||
EBITDA YoY % growth | -257.89M -128.91% | -369.68M -43.35% | -332.798M 9.98% | -7.911M 97.62% | N/A | ||||||
EBIT YoY % growth | -265.8M -130.13% | -399.4M -50.26% | -371.71M 6.93% | -33.073M 91.10% | N/A | ||||||
Operating Margin | -129.79% | -94.60% | -59.84% | -3.97% | N/A | ||||||
EPS YoY % growth | N/A | -0.70 | -0.28 60.00% | 0.03 108.97% |
All data in USD
Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | -0.05 67.14% | |||||||||||
Revenue Q2Q % growth | 184.71M 38.46% | |||||||||||
EBITDA Q2Q % growth | -19.654M | |||||||||||
EBIT Q2Q % growth | -25.141M 78.21% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2024 Q2Q % growth | -0.02 84.62% | -0.04 | 0.02 | 52.01% |
Q3 2024 Q2Q % growth | -0.03 81.25% | -0.08 | 0.05 | 64.00% |
Q2 2024 Q2Q % growth | -0.08 60.00% | -0.15 | 0.07 | 45.25% |
Q1 2024 Q2Q % growth | -0.15 28.57% | -0.17 | 0.02 | 11.63% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2024 Q2Q % growth | 174.175M 38.12% | 173.04M | 1.135M | 0.66% |
Q3 2024 Q2Q % growth | 164.165M 42.38% | 159.21M | 4.955M | 3.11% |
Q2 2024 Q2Q % growth | 149.4M 45.76% | 143.8M | 5.6M | 3.89% |
Q1 2024 Q2Q % growth | 133.4M 70.37% | 139.36M | -5.96M | -4.28% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | -73.94% | -55.86% | 327.6% |
Revenue | 0% | 0.1% | 0.16% | 2.36% |